natgillin/translations-raw huggingface dataset:
Such review should consider the impact of this Regulation on micro, small and medium-sized enterprises, public research institutions and specific sectors, as well as relevant developments at the international level, in particular those related to the ABS Clearing House.
Tak pregled bi moral upoštevati vpliv te uredbe na mikropodjetja, mala in srednja podjetja, javne raziskovalne zavode in posebne sektorje ter ustrezen razvoj na mednarodni ravni, zlasti v povezavi s posredovalnico informacij o dostopu in delitvi koristi.
OJ L 150, 20.5.2014, p.
UL L 150, 20.5.2014, str. 59.
59.
PRILOGA I
ANNEX I
Informacije, ki jih je treba predložiti z zahtevo za vključitev v register zbirk v skladu s členom 3(1)
Information to be provided with a request for inclusion in the register of collections pursuant to Article 3(1)
DEL A
PART A
Informacije, ki se vključijo v register
Information to be included in the register
V skladu s členom 3(1) je treba z zahtevo za vključitev v register zbirk predložiti naslednje informacije:
Pursuant to Article 3(1) the information to be provided with a request for inclusion in the register of collections is as follows:
Informacije o imetniku zbirke (ime, vrsta subjekta, naslov, elektronska pošta, telefonska številka).
Information on the holder of the collection (name, type of entity, address, e-mail, telephone number).
Informacije o tem, ali se zahtevek nanaša na zbirko ali del zbirke.
Information on whether the application concerns a collection or part of a collection.
Informacije o zbirki ali njenem ustreznem delu (ime; identifikator (koda/številka), kadar je na voljo, naslov(i), spletišče, kadar je na voljo, povezava do spletne podatkovne baze zbirke genskih virov, kadar je na voljo).
Information on the collection or the relevant part thereof (name; identifier (code/ number), where available; address(es), website, where available; link to the collection's online database of genetic resources, where available).
Kratek opis zbirke ali njenega zadevnega dela.
A brief description of the collection or the relevant part thereof.
Kadar se v register vključi samo del zbirke, bi bilo treba predložiti podrobnosti o zadevnih delih in njihovih posebnostih.
Where only part of a collection is to be included in the register, details on the relevant part(s) and its(their) distinctive features should be provided.
Kategorija zbirke
Collection category
V zahtevku bi morale biti predložene informacije o kategoriji, v katero spada zbirka ali njen del.
The application should provide information on the category to which the collection or part thereof belongs.
Tabela kategorij
Table of categories
Opombe
Notes
Specifičnosti
Specificities
Celotni osebki [1]
Entire specimens [1]
Deli
Parts
Semena, spolne spore ali zarodki
Seeds, sexual spores, or embryos
Gamete
Gametes
Somatske celice
Somatic cells
Nukleinske kisline
Nucleic acids
Drugi deli [2]
Other parts [2]
Živali
Animal
Vretenčarji
Vertebrate
Nevretenčarji
Invertebrate
Rastline
Plants
Alge
Algae
Enoceličarji
Protista
Glive
Fungi
Bakterije
Bacteria
Arheje
Archaea
Virusi
Viruses
Druge skupine [3]
Other groupings [3]
DEL B
PART B
Dokaz o zmožnosti zbirke ali njenega ustreznega dela, da izpolnjuje določbe iz člena 5(3) Uredbe (EU) št. 511/2014
Evidence of the capacity of the collection or of the relevant part thereof to comply with Article 5(3) of Regulation (EU) No 511/2014
K zahtevku je lahko priložena kakršna koli naslednja dokumentacija (ali navedena povezava) kot dokaz o zmožnosti zbirke ali njenega ustreznega dela, da je v skladu s členom 5(3) Uredbe (EU) št. 511/2014:
Any of the following documentation may be attached (or linked) to the application as evidence of the capacity of the collection or the relevant part thereof to comply with Article 5(3) of Regulation (EU) No 511/2014:
nacionalni ali mednarodni kodeksi ravnanja, smernice ali standardi, ki so jih razvila združenja ali organizacije in jih zbirke upoštevajo, ter informacije v zvezi z instrumenti zbirke za uporabo navedenih kodeksov ravnanja, smernic ali standardov,
codes of conduct, guidelines or standards, whether national or international, developed by associations or organisations, and adhered to by the collection, and information relating to the collection's instruments for the application of those codes of conduct, guidelines or standards;
ustrezna načela, smernice, kodeksi ravnanja ali priročniki o postopkih, pripravljeni in uporabljeni v zbirki, ter kakršni koli dodatni instrumenti za njihovo uporabo,
relevant principles, guidelines, codes of conduct or manuals of procedures, developed and applied within the collection, and any additional instruments for their application;
certificiranje zbirke v okviru ustreznih nacionalnih ali mednarodnih shem,
certification of the collection under relevant schemes, whether national or international;
informacije o vključenosti zbirke v mednarodne mreže zbirk in o povezanih zahtevkih za vključitev v register zbirk, ki jih vložijo partnerske zbirke v drugih državah članicah (neobvezno),
information about participation of the collection in any international collection networks, and about associated applications for inclusion in the register of collections filed by partner collections in other Member States (optional);
vsa ostala ustrezna dokumentacija.
any other relevant documentation.
Kadar ne gre za določene dele osebka, je treba izpolniti ustrezno celico v stolpcu „celotni osebki“.
When no particular parts of a specimen are concerned, refer to the appropriate cell of ‘entire specimens’.
Kategorija „Drugi deli“ vključuje nespolne reproduktivne dele, strukture nespolnega razmnoževanja, kot so steblo, potaknjenec, gomolj, korenika.
‘Other parts’ include asexual reproductive parts, vegetative reproduction structures, such as stem, cutting, tuber, rhizomes.
Kategorija „Druge skupine“ vključuje sluzasto plesen itd.
‘Other groupings’ include slime molds, etc.
PRILOGA II
ANNEX II
Predloga za izjavo o potrebni skrbnosti, ki se predloži na stopnji financiranja raziskav v skladu s členom 5(2)
Template for a due diligence declaration to be submitted at the stage of research funding pursuant to Article 5(2)
Informacije, ki se pošljejo posredovalnici informacij o dostopu in delitvi koristi v skladu s členom 7(3) Uredbe (EU) št. 511/2014
Information to be transmitted to the ABS Clearing House pursuant to Article 7(3) of Regulation (EU) No 511/2014
Če so predložene informacije tajne v smislu člena 7(5) Uredbe (EU) št. 511/2014, jih vseeno predložite, označite ustrezno okence in utemeljite tajnost na koncu te priloge.
If the information provided is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014, please provide it nonetheless, tick the respective box and provide the justification for confidentiality at the end of this Annex.
Če ste bistvene informacije (na primer o genskih virih ali tradicionalnem znanju v zvezi z genskimi viri, kraju dostopa, načinu uporabe), brez katerih evidenca ne bi bila objavljena v posredovalnici informacij o dostopu in delitvi koristi, označili kot tajne, te informacije ne bodo poslane posredovalnici informacij o dostopu in delitvi koristi, lahko pa bodo neposredno poslane pristojnim organom države ponudnice.
If you marked as confidential essential information (such as about the genetic resources or traditional knowledge associated with genetic resources, access place, form of utilisation), without which the record would not be published on the website of the ABS Clearing House, this information will not be shared with the ABS Clearing House, but it may be passed on directly to the competent authorities of the provider country.
Za prejeta nepovratna sredstva se zahteva vsaj ena izjava, tj. različni prejemniki nepovratnih sredstev lahko prek koordinatorja projektov predložijo posamezne izjave ali skupno izjavo.
At least one declaration is required per grant received, i.e. different recipients under one grant may choose to submit either individual declarations or a joint declaration, through the project coordinator.
To izjavo podajam za uporabo naslednjega:
I am making this declaration for the utilisation of:
Označite ustrezno okence ali okenca:
Please tick the appropriate box or boxes:
☐ Genski viri
☐ Genetic resources
☐ Tradicionalno znanje v zvezi z genskimi viri
☐ Traditional knowledge associated with genetic resources
Predmet raziskav ali identifikacijska koda nepovratnih sredstev:
Subject matter of the research or identification code of the grant:
☐ Tajno
☐ Confidential
Prejemnik ali prejemniki sredstev, vključno s kontaktnimi podatki:
Recipient or recipients of funding, including contact details:
Ime:
Address:
Elektronska pošta:
E-mail:
Telefon:
Telephone:
Spletišče, kadar je na voljo:
Website, where available:
Informacije o ravnanju s potrebno skrbnostjo:
Information on exercise of due diligence:
☐ Mednarodno priznano potrdilo o skladnosti (i) je bilo izdano za moj dostop (dostop subjekta) ali (ii) vključuje pogoje tega dostopa do genskih virov in tradicionalnega znanja v zvezi z genskimi viri.
☐ An internationally recognised certificate of compliance (i) was issued for my (entity's) access or (ii) covers the terms of this access to the genetic resource(s) and traditional knowledge associated with genetic resources.
Kadar označite to okence, navedite enotni identifikator mednarodno priznanega potrdila o skladnosti:
Where this box is ticked, please indicate the unique identifier of the internationally recognised certificate of compliance:
Nadaljujte s točko 1 dela B.
Please go to point 1 of Part B.
Kadar okence iz točke (a) ni bilo označeno, vpišite naslednje informacije:
Where the box in point (a) has not been ticked, please fill in the following information:
Kraj dostopa:
Place of access:
Opis uporabljenih genskih virov ali tradicionalnega znanja v zvezi z genskimi viri ali enotnih identifikatorjev, kadar so na voljo:
Description of the genetic resources or traditional knowledge associated with genetic resources utilised; or unique identifier(s), where available:
Identifikator dovoljenja za dostop ali njegov ekvivalent [1], kadar je na voljo:
Identifier of access permit or its equivalent [1], where available:
Nadaljujte s točko 2 dela B.
Please go to point 2 of Part B.
Informacije, ki se ne pošljejo posredovalnici informacij o dostopu in delitvi koristi
Information not to be transmitted to the ABS Clearing House
Izjavljam, da bom hranil in naslednjim uporabnikom posredoval izvod mednarodno priznanega potrdila o skladnosti ter informacije o vsebini medsebojno dogovorjenih pogojev, pomembnih za naslednje uporabnike.
I declare that I will keep and transfer to subsequent user(s) a copy of the internationally recognised certificate of compliance as well as information on the content of the mutually agreed terms relevant for subsequent users.
Nadaljujte s točko 3.
Please go to point 3.
Izjavljam, da imam informacije, ki jih bom hranil in posredoval naslednjim uporabnikom, o:
I declare that I am in possession of the following information, which I will keep and transfer to subsequent user(s):
datumu dostopa,
date of access;
osebi ali subjektu, ki je podelila oz. podelil predhodno privolitev, kadar je to primerno,
person or entity having granted prior informed consent, where applicable;
osebi ali subjektu, ki ji oz. mu je bila podeljena predhodna privolitev (kadar je to primerno), če ni bila podeljena neposredno meni ali mojemu subjektu,
person or entity to whom prior informed consent was granted (where applicable), if not granted directly to me or my entity;
medsebojno dogovorjenih pogojih, kadar je to primerno,
mutually agreed terms, where applicable;
viru, od katerega sem jaz ali moj subjekt pridobil genski vir ali tradicionalno znanje v zvezi z genskimi viri,
the source from which I or my entity obtained the genetic resource and traditional knowledge associated with genetic resources;
o tem, ali obstajajo pravice in obveznosti v zvezi z dostopom in delitvijo koristi, vključno s pravicami in obveznostmi glede nadaljnje uporabe in trženja.
presence or absence of rights and obligations relating to access and benefit-sharing, including rights and obligations regarding subsequent applications and commercialisation.
Kadar so bili genski viri pridobljeni iz registrirane zbirke, navedite registracijsko kodo zbirke:
Where the genetic resource(s) was(were) obtained from a registered collection, please provide the registration code of the collection:
Nepovratna sredstva za raziskave se financirajo iz naslednjih virov:
The research grant is funded by the following sources:
Zasebni ☐
Private ☐
Javni ☐
Public ☐
Države članice, v katerih se izvajajo ali so se izvajale raziskave, ki vključujejo uporabo genskih virov in tradicionalnega znanja v zvezi z genskimi viri:
Member State(s) in which the research involving utilisation of genetic resources and traditional knowledge associated with genetic resources takes place or has taken place:
Tajnost
Confidentiality
Če ste izjavili, da so nekatere informacije tajne v smislu člena 7(5) Uredbe (EU) št. 511/2014, navedite razloge za vsako informacijo, za katero ste izjavili, da je tajna:
If you have declared that some information is confidential within the meaning of Article 7(5) of Regulation (EU) No 511/2014, please state the reasons for each piece of information for which you have declared that confidentiality applies:
Datum:
Signature [2]:
Dokaz o odločitvi za odobritev predhodne privolitve ali odobritve za dostop do genskih virov ali tradicionalnega znanja v zvezi z genskimi viri.
Evidence of the decision to grant prior informed consent or approval for access to genetic resources and traditional knowledge associated with genetic resources.
Podpis prejemnika sredstev ali pristojnega posameznika v raziskovalni ustanovi (organizaciji).
Signature of the recipient of funding or individual responsible within the research institution.
PRILOGA III
ANNEX III
Predloga za izjavo o potrebni skrbnosti, ki se predloži na zadnji stopnji razvoja proizvoda v skladu s členom 6(1)
Template for a due diligence declaration to be submitted at the stage of final development of a product pursuant to Article 6(1)
Če ste bistvene informacije (na primer o genskih virih ali tradicionalnem znanju v zvezi z genskimi viri, kraju dostopa, načinu uporabe), brez katerih evidenca ne bi bila objavljena na spletišču posredovalnice informacij o dostopu in delitvi koristi, označili kot tajne, te informacije ne bodo poslane posredovalnici informacij o dostopu in delitvi koristi, lahko pa bodo neposredno poslane pristojnim organom države ponudnice.
If you marked as confidential essential information (such as about the genetic resources or traditional knowledge associated with genetic resources, access place, form of utilisation) without which the record would not be published on the website of the ABS Clearing House, this information will not be shared with the Clearing House but it may be passed on directly to the competent authorities of the provider country.
Če je uporaba vključevala več kot en genski vir ali morebitno tradicionalno znanje v zvezi z genskimi viri, predložite ustrezne informacije za vsak uporabljen genski vir ali morebitno tradicionalno znanje.
If the utilisation has involved more than one genetic resource or any traditional knowledge associated with genetic resources, please provide relevant information for each genetic resource or any traditional knowledge utilised.
Izjavljam, da sem izpolnil obveznosti iz člena 4 Uredbe (EU) št. 511/2014.
I declare that I have fulfilled the obligations under Article 4 of Regulation (EU) No 511/2014.
Ime proizvoda ali opis rezultata uporabe [1] ali opis izida uporabe [2]:
Name of the product or description of the result of the utilisation [1] or description of the outcome of the utilisation [2]:
Kontaktni podatki uporabnika:
Contact details of the user:
Izjava se da v naslednjem primeru:
The declaration is made on the occasion of the following event:
Označite ustrezno okence:
Please tick the appropriate box:
☐ (a) zaprosi se za dovoljenje za trženje ali promet za proizvod, razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri,
☐ (a) market approval or authorisation is sought for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
☐ (b) potrebna je priglasitev, preden je proizvod, razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri, prvič dan na trg Unije,
☐ (b) a notification required prior to placing for the first time on the Union market is made for a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources;
☐ (c) na trg Unije je prvič dan proizvod, ki je bil razvit prek uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri, in za katerega niso potrebni niti dovoljenje za trženje ali promet niti priglasitev,
☐ (c) placing for the first time on the Union market a product developed via the utilisation of genetic resources and traditional knowledge associated with genetic resources, for which no market approval, authorisation or notification is required;
☐ (d) rezultat uporabe je prodan ali na kakršen koli drug način posredovan fizični ali pravni osebi v Uniji, da navedena oseba izvede eno od dejavnosti iz točk (a), (b) in (c),
☐ (d) the result of the utilisation is sold or transferred in any other way to a natural or legal person within the Union in order for that person to carry out one of the activities referred to in points (a), (b) and (c);
☐ (e) uporaba v Uniji se je končala in njen rezultat prodal ali na kakršen koli drug način posredoval fizični ali pravni osebi zunaj Unije.
☐ (e) the utilisation has ended in the Union and its outcome is sold or transferred in any other way to a natural or legal person outside the Union.
Opis uporabljenega genskega vira ali tradicionalnega znanja v zvezi z genskimi viri ali enotnimi identifikatorji, kadar so na voljo:
Description of the genetic resource or traditional knowledge associated with genetic resources utilised, or unique identifier(s), where available:
Datum dostopa:
Date of access:
Identifikator dovoljenja za dostop ali njegov ekvivalent [3], kadar je na voljo:
Identifier of access permit or its equivalent [3], where available:
Oseba ali subjekt, ki je podelila oz. podelil predhodno privolitev:
Person or entity who granted prior informed consent:
Oseba ali subjekt, ki ji oz. mu je bila podeljena predhodna privolitev:
Person or entity to whom the prior informed consent was granted:
Ali je uporaba genskih virov in tradicionalnega znanja v zvezi z genskimi viri predmet medsebojno dogovorjenih pogojev?
Is the utilisation of genetic resources and traditional knowledge associated with genetic resources subject to mutually agreed terms?
Da ☐
Yes ☐
Ne ☐
No ☐
Neposredni vir genskega vira in tradicionalnega znanja v zvezi z genskimi viri:
Direct source of the genetic resource and the traditional knowledge associated with genetic resources:
Ali obstajajo kakšne omejitve v medsebojno dogovorjenih pogojih, ki omejujejo morebitno uporabo genskih virov ali tradicionalnega znanja v zvezi z genskimi viri, npr. omogočanje samo nekomercialne uporabe?
Are there any restrictions in the mutually agreed terms limiting the possible utilisation of the genetic resource(s) or the traditional knowledge associated with genetic resources, e.g. allowing for non-commercial utilisation only?
Ni relevantno ☐
Not applicable ☐
Ali so bile v medsebojno dogovorjenih pogojih dogovorjene pravice in obveznosti glede nadaljnje uporabe in trženja?
Have there been rights and obligations agreed regarding subsequent applications and commercialisation in the mutually agreed terms?
Če so bili genski viri pridobljeni iz registrirane zbirke, navedite registracijsko kodo zbirke:
If the genetic resource(s) was(were) obtained from a registered collection, please provide the registration code of the collection:
Če izvajate najboljšo prakso, priznano v skladu s členom 8 Uredbe (EU) št. 511/2014, navedite registracijsko številko:
If you are implementing a best practice recognised under Article 8 of Regulation (EU) No 511/2014, please provide the registration number:
Katera kategorija najbolje opredeli vaš proizvod (neobvezno)?
Which category best describes your product (optional)?
☐ (a) kozmetika
☐ (a) cosmetics
☐ (b) zdravila
☐ (b) medicinal products
☐ (c) hrana in pijača
☐ (c) food and beverage
☐ (d) biotično zatiranje
☐ (d) biological control
☐ (e) žlahtnjenje rastlin
☐ (e) plant breeding
☐ (f) vzreja živali
☐ (f) animal breeding
☐ (g) drugo, navedite:
☐ (g) other, please specify:
Države članice, v katerih se je izvajala uporaba genskih virov in tradicionalnega znanja v zvezi z genskimi viri:
Member State(s) in which the utilisation of genetic resources and traditional knowledge associated with genetic resources has taken place:
Države članice, v katerih se proizvod da na trg po postopku za odobritev, dovoljenje ali priglasitev iz člena 6(2)(a) in (b) Uredbe Komisije (EU) 2015/1866 ali da na trg v skladu s členom 6(2)(c) navedene uredbe:
Signature [4]:
„Rezultat uporabe genskih virov in tradicionalnega znanja v zvezi z genskimi viri“ pomeni proizvode, prekurzorje ali predhodnike proizvoda ter dele proizvodov, ki se vključijo v končni proizvod, odtise ali zasnove, na osnovi katerih bi se lahko izvedli izdelava in proizvodnja brez nadaljnje uporabe genskega vira ali tradicionalnega znanja v zvezi z genskimi viri.
‘Result of the utilisation of genetic resources and traditional knowledge associated with genetic resources’ means products, precursors or predecessors to a product, as well as parts of products to be incorporated into a final product, blueprints or designs, based on which manufacturing and production could be carried out without further utilisation of the genetic resource and traditional knowledge associated with genetic resources.
Kadar se je uporaba v Uniji končala in njen rezultat prodal ali na kakršen koli drug način posredoval fizični ali pravni osebi zunaj Unije.
Where the utilisation in the Union has ended and its outcome is sold or transferred in any other way to a natural or legal person outside the Union.
Podpis osebe, pravno odgovorne za zadnjo stopnjo razvoja proizvoda.
Signature of the person legally responsible for the stage of final development of a product.
PRILOGA IV
ANNEX IV
Informacije, ki jih je treba predložiti z zahtevkom za priznanje najboljše prakse v skladu s členom 8(1)
Information to be provided with an application for recognition of best practice pursuant to Article 8(1)
V skladu s členom 8(1) je treba z zahtevkom za priznanje najboljše prakse predložiti naslednje informacije:
Pursuant to Article 8(1) the information to be provided with the application for recognition of best practice is as follows:
Informacije, ali je zahtevek vložen v imenu združenja uporabnikov ali drugih zainteresiranih strani.
Information whether the application is made on behalf of an association of users or other interested parties.
Kontaktne podatke združenja uporabnikov ali drugih zainteresiranih strani (ime, naslov, elektronska pošta, telefon in spletišče, kadar je na voljo).
Contact details of the association of users or other interested parties (name, address, e-mail, telephone, and website, where available).
Če je zahtevek vložilo združenje uporabnikov, je treba predložiti naslednje:
If the application is made by an association of users, the following should be provided:
dokaz o sedežu v skladu z zahtevami države članice, v kateri se nahaja vložnik,
evidence of being established in accordance with the requirements of the Member State in which the applicant is located;
opis organizacije in strukture združenja.
description of the organisation and structure of the association.
Če so zahtevek vložile druge zainteresirane strani, bi morale pojasniti razloge za legitimni interes glede predmeta urejanja v Uredbi (EU) št. 511/2014.
If the application is made by other interested parties, the reasons for having legitimate interest in the subject matter of Regulation (EU) No 511/2014 should be explained.
Iz predloženih informacij bi moralo biti razvidno, kako je vložnik vključen v razvoj ukrepov in politik, povezanih z genskimi viri, ali kako vložnik dostopa, zbira, posreduje ali trži genske vire in tradicionalno znanje v zvezi z genskimi viri.